In control subjects, HSPB1, SMAD3 and HSPA1A decreased significantly, whilst MAPKAPK5 increased significantly in controls from baseline to hypoglycemia whilst, in T2D, PPP3CA increased and EPHA2 decreased. The gene discussed is PPP3CA; the disease is Hypoglycemia.